83 related articles for article (PubMed ID: 7851812)
1. Suppression of plasma insulin-like growth factor-1 levels in healthy, nulliparous, young women using low dose oral contraceptives.
Jernström H; Olsson H
Gynecol Obstet Invest; 1994; 38(4):261-5. PubMed ID: 7851812
[TBL] [Abstract][Full Text] [Related]
2. Associations of Serum Levels of Sex Hormones in Follicular and Luteal Phases of the Menstrual Cycle with Breast Tissue Characteristics in Young Women.
Linton L; Taylor M; Dunn S; Martin L; Chavez S; Stanitz G; Huszti E; Minkin S; Boyd N
PLoS One; 2016; 11(10):e0163865. PubMed ID: 27716810
[TBL] [Abstract][Full Text] [Related]
3. Reduced testosterone, 17 beta-oestradiol and sexual hormone binding globulin, and increased insulin-like growth factor-1 concentrations, in healthy nulligravid women aged 19-25 years who were first and/or second degree relatives to breast cancer patients.
Jernström HC; Olsson H; Borg A
Eur J Cancer Prev; 1997 Aug; 6(4):330-40. PubMed ID: 9370095
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-1 in relation to adult weight and birth weight in healthy nulliparous women.
Jernström H; Olsson H
Int J Gynaecol Obstet; 1998 Jul; 62(1):11-8. PubMed ID: 9722119
[TBL] [Abstract][Full Text] [Related]
6. Changes in insulin receptors during oral contraception.
De Pirro R; Forte F; Bertoli A; Greco AV; Lauro R
J Clin Endocrinol Metab; 1981 Jan; 52(1):29-33. PubMed ID: 7451643
[TBL] [Abstract][Full Text] [Related]
7. Breast size in relation to endogenous hormone levels, body constitution, and oral contraceptive use in healthy nulligravid women aged 19-25 years.
Jernström H; Olsson H
Am J Epidemiol; 1997 Apr; 145(7):571-80. PubMed ID: 9098173
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of relaxin during the menstrual cycle and oral contraceptive use.
Wreje U; Kristiansson P; Aberg H; Byström B; von Schoultz B
Gynecol Obstet Invest; 1995; 39(3):197-200. PubMed ID: 7789917
[TBL] [Abstract][Full Text] [Related]
9. Plasma insulin-like growth factor-I, CA-125, estrogen, and progesterone in women with leiomyomas.
Dawood MY; Khan-Dawood FS
Fertil Steril; 1994 Apr; 61(4):617-21. PubMed ID: 8150101
[TBL] [Abstract][Full Text] [Related]
10. Plasma prolactin in relation to menstrual cycle phase, oral contraceptive use, arousal time and smoking habits.
Jernström H; Knutsson M; Taskila P; Olsson H
Contraception; 1992 Dec; 46(6):543-8. PubMed ID: 1493714
[TBL] [Abstract][Full Text] [Related]
11. Fasted plasma asprosin concentrations are associated with menstrual cycle phase, oral contraceptive use and training status in healthy women.
Leonard AN; Shill AL; Thackray AE; Stensel DJ; Bishop NC
Eur J Appl Physiol; 2021 Mar; 121(3):793-801. PubMed ID: 33289860
[TBL] [Abstract][Full Text] [Related]
12. Insulin receptors in circulating erythrocytes and monocytes from women on oral contraceptives or pregnant women near term.
Tsibris JC; Raynor LO; Buhi WC; Buggie J; Spellacy WN
J Clin Endocrinol Metab; 1980 Oct; 51(4):711-7. PubMed ID: 6998996
[TBL] [Abstract][Full Text] [Related]
13. C-Reactive protein and insulin growth factor 1 serum levels during the menstrual cycle in adolescents with Type 1 diabetes.
Codner E; Merino PM; Martínez D; Lopez P; Godoy C; Iñiguez G; Cassorla F; Perez-Bravo F
Diabet Med; 2016 Jan; 33(1):70-6. PubMed ID: 26043285
[TBL] [Abstract][Full Text] [Related]
14. Follicular fluid concentrations of free insulin-like growth factor (IGF)-I during follicular development in mares.
Spicer LJ; Santiago CA; Davidson TR; Bridges TS; Chamberlain CS
Domest Anim Endocrinol; 2005 Nov; 29(4):573-81. PubMed ID: 16213990
[TBL] [Abstract][Full Text] [Related]
15. Patterns of serum LH and FSH in response to 4-hour infusions of luteinizing hormone releasing hormone in normal women during menstrual cycle, on oral contraceptives, and in postmenopausal state.
de Kretser DM; Burger HG; Dumpys R
J Clin Endocrinol Metab; 1978 Feb; 46(2):227-35. PubMed ID: 374423
[TBL] [Abstract][Full Text] [Related]
16. Effects of menstrual cycle and oral contraceptive use on serum levels of lipid-soluble antioxidants.
Palan PR; Magneson AT; Castillo M; Dunne J; Mikhail MS
Am J Obstet Gynecol; 2006 May; 194(5):e35-8. PubMed ID: 16647895
[TBL] [Abstract][Full Text] [Related]
17. Growth and obesity and its association with plasma level of steroid hormones and insulin-like growth factor-I (IGF-I) in Slovak female students.
Zatko T; Matejovicova B; Boledovicova M; Vondrakova M; Bezakova A; Sirotkin AV
Bratisl Lek Listy; 2013; 114(10):573-80. PubMed ID: 24156681
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
Lemay A; Dewailly SD; Grenier R; Huard J
J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
[TBL] [Abstract][Full Text] [Related]
19. Effect of oral contraceptives and ovarian cycle on platelet function.
Roell A; Schueller P; Schultz A; Losel R; Wehling M; Christ M; Feuring M
Platelets; 2007 Mar; 18(2):165-70. PubMed ID: 17365866
[TBL] [Abstract][Full Text] [Related]
20. Effects of sex, phase of the menstrual cycle and gonadal hormones on pain in healthy humans.
Ring C; Veldhuijzen van Zanten JJ; Kavussanu M
Biol Psychol; 2009 Jul; 81(3):189-91. PubMed ID: 19393713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
